Drug Co. Manager Pleads Guilty To Bextra Charges

Law360, New York (April 6, 2009, 12:00 AM EDT) -- Two months after Pfizer Inc. agreed to pay $2.3 million to settle allegations that it improperly marketed the now-defunct anti-inflammatory drug Bextra, a regional manager responsible for sales of the former blockbuster has agreed to plead guilty to distribution of a misbranded drug.

Branchburg, N.J.-resident Mary Holloway, 47, pled guilty to the one count of information misdemeanor in the U.S. District Court for the District of Massachusetts, the U.S. Attorney's Office said Thursday.

The office described Holloway as a regional manager at "a pharmaceutical company," and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.